Internal Medicine, Nephrology · Philadelphia, PA
NPI
1407059710
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3400 Spruce Street, 1 Founders
Philadelphia, PA, 19104
Phone (215) 662-2638
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
813 services
Medicare patients, 2024
272
Average age 70
Drug cost, 2024
$252K
818 prescriptions
Company payments, 2025
$148
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Siddharth P Shah was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 133 times for 91 patients. In total Siddharth P Shah billed 813 services in 17 codes, and Medicare paid $85K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 133 | 91 | $12.96 | $1,723 |
| 99215 Office E&M - Established | Office | 128 | 88 | $100.72 | $13K |
| 90960 ESRD Related Services (not dialysis) | Office | 116 | 23 | $287.60 | $33K |
| 99215 Office E&M - Established | Facility | 81 | 50 | $103.82 | $8,409 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 75 | 48 | $12.90 | $968 |
| 99233 Hospital E&M - Subsequent | Facility | 61 | 30 | $95.17 | $5,805 |
| 90999 Hemodialysis | Facility | 54 | 20 | $70.26 | $3,794 |
| 90935 Hemodialysis | Facility | 32 | 22 | $56.74 | $1,816 |
| 99223 Hospital E&M - Initial | Facility | 30 | 29 | $139.29 | $4,179 |
| 99232 Hospital E&M - Subsequent | Facility | 21 | 14 | $63.33 | $1,330 |
| 99205 Office E&M - New | Office | 18 | 18 | $140.24 | $2,524 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $98.57 | $1,084 |
By year: 2022 $89K for 685 services; 2023 $82K for 690 services; 2024 $85K for 813 services.
Medicare prescription drug claims, 2024
In 2024, the drug Siddharth P Shah prescribed most often to Medicare patients was Potassium Citrate Er (Potassium Citrate), with 168 prescriptions and refills. In total Siddharth P Shah wrote 818 Medicare prescriptions that cost $252K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Citrate Er Potassium Citrate | 168 | 395 | 48 | $26K |
| Indapamide Generic | 111 | 293 | 42 | $1,580 |
| Potassium Chloride Generic | 85 | 148 | 17 | $2,691 |
| Hydrochlorothiazide Generic | 73 | 172 | 19 | $451 |
| Amlodipine Besylate Generic | 52 | 132 | 16 | $493 |
| Calcitriol Generic | 45 | 82 | Under 11 | $1,216 |
| Chlorthalidone Generic | 33 | 63 | Under 11 | $517 |
| Allopurinol Generic | 28 | 66 | Under 11 | $178 |
| Furosemide Generic | 22 | 45 | 11 | $81.8 |
| Losartan Potassium Generic | 21 | 51 | Under 11 | $162 |
| Lisinopril Generic | 18 | 54 | 11 | $125 |
| Velphoro Sucroferric Oxyhydroxide | 18 | 18 | Under 11 | $32K |
| Spironolactone Generic | 15 | 35 | Under 11 | $51.09 |
| Sevelamer Carbonate Generic | 12 | 20 | Under 11 | $890 |
| Thiola Ec Tiopronin | 11 | 11 | Under 11 | $167K |
Brand drugs: - claims; generic drugs: 703 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Siddharth P Shah $148 ($148 in general payments such as food, travel and fees) from 3 companies. The largest payer was Cycle Pharmaceuticals Inc with $61.11.
| Company | Payments | Amount |
|---|---|---|
| Cycle Pharmaceuticals Inc | 1 | $61.11 |
| Abbott Laboratories ABT | 1 | $45.8 |
| Fresenius USA Marketing, Inc. | 2 | $40.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.